Using Neuromodulation for Migraine
Bioelectronics Company That is Targeting Migraine Treatment Raises $6 Million July 4, 2017 – Israel-based medical device company Theranica Bio-electronics raised $6 million in Series A financing, which it will use on the regulatory process for its first product, an